Castle Wealth Management’s Precigen PGEN Stock Holding History

Castle Wealth Management’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-100	Closed	–	–	716
2022 Q2	$0	Buy	+100	New	+$148	﹤0.01%	695

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Castle Wealth Management's PGEN Position: Q3 2022 in Review

Castle Wealth Management sold out of Precigen (PGEN) in Q3 2022, closing a stake of 100 shares.

Castle Wealth Management first reported a position in PGEN in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 165 funds tracked by Wall St. Rank hold PGEN as of Q3 2022.

Castle Wealth Management reported no remaining Precigen position as of Q3 2022 after selling out during the quarter.
Castle Wealth Management sold 100 Precigen shares in Q3 2022.
Castle Wealth Management first reported a position in Precigen in Q2 2022 and held it in 1 quarter.
Castle Wealth Management's Precigen position peaked at $0 in Q2 2022.
165 funds tracked by Wall St. Rank held Precigen as of Q3 2022.

Based on Castle Wealth Management's 13F filing for Q3 2022, filed 7 Nov 2022.